# TIOPRONIN
> **ANDA216456** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2024-07-22
## Drug
- **FDA Application Number:** ANDA216456
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TIOPRONIN
- **Generic name:** TIOPRONIN
- **Active ingredients:** TIOPRONIN
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2024-07-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216456)
---
*AI Analytics · CC0 1.0*